Stock AXDX ACCELERATE DIAGNOSTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Accelerate Diagnostics, Inc.

Equities

AXDX

US00430H2013

Market Closed - Nasdaq
Other stock markets
 21:30:00 26/04/2024 BST 		5-day change 1st Jan Change
0.9301 USD -1.61% Intraday chart for Accelerate Diagnostics, Inc. +8.28% -76.27%
04-19 Certain Warrants of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 19-APR-2024. CI
04-19 Certain Restricted Stock Units of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 19-APR-2024. CI

Evolution of the average Target Price on Accelerate Diagnostics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

a719ed.5Xf1-nbV6ZNKa9rEkPrblAkrXpQZUMdig8yNy5lPWLw.ozSmghzgpusuWo6G_JSQwF5nMKFuFbRPxfXV-uB9b9K9BarNAJTQ3SgZ6g~8877adc0d0b62fe391be7e7c656f5b69

Analyst Recommendations on Accelerate Diagnostics, Inc.

Craig Hallum Cuts Accelerate Diagnostics Price Target to $0.60 From $2, Maintains Hold Rating MT
Craig-Hallum Downgrades Accelerate Diagnostics to Hold From Buy; Price Target is $5 MT
Craig-Hallum Adjusts Accelerate Diagnostics' Price Target to $9 from $12, Maintains Buy Rating MT
ACCELERATE DIAGNOSTICS : Piper Sandler Adjusts Price Target on Accelerate Diagnostics to $9 From $12, Maintains Overweight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.9301
Average target price
-

Consensus detail

Consensus revision (last 18 months)

Analysts covering Accelerate Diagnostics, Inc.

Craig-Hallum

Ratings for Accelerate Diagnostics, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. AXDX Stock
  4. Consensus Accelerate Diagnostics, Inc.